Fizazi, Ariane, et al. “High BRAF V600 Mutation Level Associated With Worse Outcome in Metastatic Melanoma Patients Receiving BRAF and MEK Inhibitors”. Acta Dermato-Venereologica, vol. 104, Nov. 2024, p. adv40913, doi:10.2340/actadv.v104.40913.